BSYJF affects AD by regulating MF, protein kinase activity, neurotransmitter receptor activity, kinase binding, protein tyrosine kinase activity, nuclear receptor activity, heme binding, heat shock protein binding, tau protein binding, G-protein-coupled neurotransmitter receptor activity, and p53 binding. This evidence concerns the gene TP53 and Alzheimer disease.